Connected profiles13
Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Obesity peptide evidence brief
A cited Obesity peptide evidence brief across 46 exact-label ClinicalTrials.gov records, 13 connected profiles, and 10 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
46 selected records.
Connected peptides
13 profiles.
Registry update years
2013–2026 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Obesity?
PeptideScanner’s selected collection contains 46 retained ClinicalTrials.gov records carrying the exact condition label “Obesity,” connected to 13 peptide profiles across 10 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Obesity, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Trial phases6
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 3 (18)Phase 2 (10)Phase 1 (9)Phase 4 (5)Not applicable (3)Early Phase 1 (1)
Registry statuses5
Overall statuses at each retained observation, not necessarily current today.
Completed (22)Recruiting (11)Active, not recruiting (7)Not yet recruiting (4)Enrolling by invitation (2)
Across the connected peptide profiles, PeptideScanner also carries 584 selected PubMed records and 55 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Obesity unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Obesity.
Semaglutide · source record 2026-09-09
"I Believe in Santa Claus" and Ozempic: A Foucauldian Discourse Analysis of Holiday Health Advertising.
PubMed lists PMID 40536021 in Qualitative health research as Journal Article, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Tirzepatide · source record 2026-09-04
Are We Asking About Tirzepatide? Emerging Oral Health Implications for Oral Medicine Practice.
PubMed lists PMID 42695200 in Oral diseases as Letter, with publication-date metadata of 2026-09-04 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Liraglutide · source record 2026-09-08
Monitoring Liraglutide Oligomeric Interconversion and Fibril Dissociation through High-Pressure NMR Spectroscopy.
PubMed lists PMID 42708757 in Analytical chemistry as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Maridebart cafraglutide · source record 2026-08-13
Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.
PubMed lists PMID 42592044 in Antibody therapeutics as Journal Article, Review, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug maridebart-cafraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Retatrutide · source record 2025-09-02
Retatrutide.
PubMed lists PMID 39429457 in Clinical diabetes : a publication of the American Diabetes Association as Journal Article, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Glucagon · source record 2026-09-09
Targeting glucagon signaling in metabolic disorders, functional insights from zebrafish receptor knockouts.
PubMed lists PMID 42332291 in Cellular and molecular life sciences : CMLS as Journal Article, with publication-date metadata of 2026-06-22 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT03139305
PeptideScanner retained ClinicalTrials.gov record NCT03139305 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- March 30, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT04561245
PeptideScanner retained ClinicalTrials.gov record NCT04561245 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-24, and PeptideScanner's reviewed identity mapping was pemvidutide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- June 24, 2025
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT05929066
PeptideScanner retained ClinicalTrials.gov record NCT05929066 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was retatrutide.
- PeptideScanner change date
- September 9, 2026
- Cited source date
- August 21, 2026
- Evidence lane
- Clinical trials
Exact-record source chronology
Obesity registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2026
34 recordsPetrelintide · 2026-09-09
ClinicalTrials.gov record NCT06926842
Completed at the retained observation.
Open cited registry record →Tirzepatide · 2026-09-09
ClinicalTrials.gov record NCT07247084
Recruiting at the retained observation.
Open cited registry record →Tirzepatide · 2026-09-04
ClinicalTrials.gov record NCT06439277
Recruiting at the retained observation.
Open cited registry record →Mazdutide · 2026-09-04
ClinicalTrials.gov record NCT07803705
Not yet recruiting at the retained observation.
Open cited registry record →Maridebart cafraglutide · 2026-09-03
ClinicalTrials.gov record NCT07684144
Recruiting at the retained observation.
Open cited registry record →Retatrutide · 2026-08-21
ClinicalTrials.gov record NCT05929066
Completed at the retained observation.
Open cited registry record →Tirzepatide · 2026-08-12
ClinicalTrials.gov record NCT07463846
Recruiting at the retained observation.
Open cited registry record →Survodutide · 2026-08-11
ClinicalTrials.gov record NCT06077864
Completed at the retained observation.
Open cited registry record →Tirzepatide · 2026-08-11
ClinicalTrials.gov record NCT06965413
Active, not recruiting at the retained observation.
Open cited registry record →Setmelanotide · 2026-08-06
ClinicalTrials.gov record NCT05093634
Completed at the retained observation.
Open cited registry record →Maridebart cafraglutide · 2026-08-04
ClinicalTrials.gov record NCT07684235
Recruiting at the retained observation.
Open cited registry record →Cagrilintide · 2026-08-04
ClinicalTrials.gov record NCT07745504
Not yet recruiting at the retained observation.
Open cited registry record →Cagrilintide · 2026-08-03
ClinicalTrials.gov record NCT07220759
Active, not recruiting at the retained observation.
Open cited registry record →Retatrutide · 2026-07-30
ClinicalTrials.gov record NCT05882045
Completed at the retained observation.
Open cited registry record →Retatrutide · 2026-07-30
ClinicalTrials.gov record NCT05929079
Completed at the retained observation.
Open cited registry record →Semaglutide · 2026-07-28
ClinicalTrials.gov record NCT07732426
Recruiting at the retained observation.
Open cited registry record →Maridebart cafraglutide · 2026-07-24
ClinicalTrials.gov record NCT07037433
Recruiting at the retained observation.
Open cited registry record →Setmelanotide · 2026-07-23
ClinicalTrials.gov record NCT07496463
Enrolling by invitation at the retained observation.
Open cited registry record →Semaglutide · 2026-07-21
ClinicalTrials.gov record NCT06299098
Active, not recruiting at the retained observation.
Open cited registry record →Semaglutide · 2026-07-16
ClinicalTrials.gov record NCT06814938
Active, not recruiting at the retained observation.
Open cited registry record →Tirzepatide · 2026-07-15
ClinicalTrials.gov record NCT06934642
Recruiting at the retained observation.
Open cited registry record →Liraglutide · 2026-07-09
ClinicalTrials.gov record NCT04775082
Active, not recruiting at the retained observation.
Open cited registry record →Tirzepatide · 2026-07-09
ClinicalTrials.gov record NCT07693608
Not yet recruiting at the retained observation.
Open cited registry record →Semaglutide · 2026-07-08
ClinicalTrials.gov record NCT05616013
Completed at the retained observation.
Open cited registry record →Tirzepatide · 2026-07-07
ClinicalTrials.gov record NCT06893211
Completed at the retained observation.
Open cited registry record →Semaglutide · 2026-07-02
ClinicalTrials.gov record NCT05371496
Enrolling by invitation at the retained observation.
Open cited registry record →Maridebart cafraglutide · 2026-07-02
ClinicalTrials.gov record NCT07037459
Recruiting at the retained observation.
Open cited registry record →Cagrilintide · 2026-06-25
ClinicalTrials.gov record NCT07607587
Recruiting at the retained observation.
Open cited registry record →Survodutide · 2026-06-15
ClinicalTrials.gov record NCT07413913
Completed at the retained observation.
Open cited registry record →Mazdutide · 2026-05-27
ClinicalTrials.gov record NCT07469800
Recruiting at the retained observation.
Open cited registry record →Mazdutide · 2026-04-21
ClinicalTrials.gov record NCT06124807
Completed at the retained observation.
Open cited registry record →Glucagon · 2026-03-30
ClinicalTrials.gov record NCT02817659
Active, not recruiting at the retained observation.
Open cited registry record →Glucagon · 2026-03-30
ClinicalTrials.gov record NCT03139305
Active, not recruiting at the retained observation.
Open cited registry record →Petrelintide · 2026-03-23
ClinicalTrials.gov record NCT06662539
Completed at the retained observation.
Open cited registry record →2025
2 recordsPemvidutide · 2025-06-24
ClinicalTrials.gov record NCT04561245
Completed at the retained observation.
Open cited registry record →Semaglutide · 2025-01-08
ClinicalTrials.gov record NCT06764056
Not yet recruiting at the retained observation.
Open cited registry record →2024
1 recordSemaglutide · 2024-08-30
ClinicalTrials.gov record NCT03574597
Completed at the retained observation.
Open cited registry record →2023
2 recordsLiraglutide · 2023-07-18
ClinicalTrials.gov record NCT03374956
Completed at the retained observation.
Open cited registry record →Liraglutide · 2023-01-20
ClinicalTrials.gov record NCT02967757
Completed at the retained observation.
Open cited registry record →2022
1 recordSemaglutide · 2022-01-19
ClinicalTrials.gov record NCT03548987
Completed at the retained observation.
Open cited registry record →2021
1 recordSemaglutide · 2021-11-11
ClinicalTrials.gov record NCT03611582
Completed at the retained observation.
Open cited registry record →2020
1 recordSemaglutide · 2020-12-24
ClinicalTrials.gov record NCT03842202
Completed at the retained observation.
Open cited registry record →2017
1 recordSemaglutide · 2017-12-02
ClinicalTrials.gov record NCT02079870
Completed at the retained observation.
Open cited registry record →2014
1 recordLeuprolide · 2014-05-14
ClinicalTrials.gov record NCT01160328
Completed at the retained observation.
Open cited registry record →2013
2 recordsLiraglutide · 2013-07-30
ClinicalTrials.gov record NCT01911468
Completed at the retained observation.
Open cited registry record →Liraglutide · 2013-07-15
ClinicalTrials.gov record NCT01899430
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.